Directorio

We are doing this study to find out if a personalized exercise program designed for lung cancer patients can help with recovery from lung surgery. The study's exercise program is delivered over the phone.

We created this registry for people with rare breast tumors to help us learn more about them and how to better treat people in the future.

If your child is eligible and you allow them to join the study, they will get a random assignment (like a coin flip) to 1 of 2 groups:<ul>
<li>One group will be treated with numbing medicine at the incision site to lower their pain after surgery</li>
<li>The other group will have the nerves around the incision site blocked using ultrasound guidance to lower their pain after surgery</li></ul>
Both of these procedures are routinely performed by clinicians to help manage pain after surgery. We do not know which procedure is better for most children, and we hope this study will help us find out.

We will also ask you and your child to fill out a few surveys during your time in the hospital. We will call you about 30 days after your child's procedure to see how they are doing and end their study participation.

We are doing this study to find out if an experimental device is a safe and effective method to repair a leaking mitral valve. The device is called MitraClip, and it is placed in the heart in a less invasive manner that uses a catheter. We want to know how well this device works compared to standard mitral valve repair surgery, which is a more invasive procedure.

We are doing this study to find out if an experimental study drug called RP1 is a safe and effective treatment for your cancer. We want to know how the drug works on its own and when it is combined with a cancer drug called nivolumab.

We are doing this study to find out if a medical technology called the Revi System active therapy (system is being implanted and activated) is better than non-active Revi system therapy (system is being implanted but not activated) for the treatment of urinary urge incontinence (UUI).

We are doing this study to find out is an experimental drug called RGX-314 can help improve or preserve vision. We will compare how this drug works to Eylea®, which is an approved therapy for age-related macular degeneration.

We are doing this study to see if an experimental drug called RMC-6236 (the study drug) is a safe and effective option for treating colorectal or pancreatic cancer when it is combined with different chemotherapy drugs.